Scientists at Harvard University invent a new vaccine technology
-
Last Update: 2020-07-06
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
scientists at Harvard University recently developed a new vaccine technologycould reduce the cost of producing vaccines in the futureAccording to a recent press release from Harvard University
the "protein-membrane vaccine" technology invented by John Mocaranos, head of the Department of Microbiology and Molecular Genetics at the university's School of Medicine, which is aimed primarily at the polysaccharide antigenMembrane polysaccharides are the main antigens involved in the protective immunity of the bacterial pathogens of the diaphragm, including theof neser bacteria,Streptococcus pneumoniae, haemophilusinfluenzae haemophilus, and Bacillus anthraxMocaranos said new pathogens,drug-resistant pathogens and the potential threat of biological terrorist attacks,make it particularly important to find new ways to develop vaccinesThe new vaccine technology not only provides a promisingfor the development of a variety of vaccines, but also potentially significantly reduce the cost of vaccine production It added Morningside Has invested in developing vaccine products that can be affordable in developing countries
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
